前收市價 | 18.64 |
開市 | 18.36 |
買盤 | 19.44 x 800 |
賣出價 | 19.52 x 100 |
今日波幅 | 18.01 - 19.50 |
52 週波幅 | 15.81 - 41.06 |
成交量 | |
平均成交量 | 1,956,863 |
市值 | 2.369B |
Beta 值 (5 年,每月) | 0.92 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -4.28 |
業績公佈日 | 2024年5月09日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 36.65 |
Investors' focus will likely be on revenues generated by Guardant Health (GH) from its precision oncology testing business.
Besides Wall Street's top -and-bottom-line estimates for Guardant Health (GH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.